Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel arylhydrocarbon receptor antagonist may protect against skin photodamage

May 22, 2007

Novel VEGF inhibitor shows therapeutic potential in psoriasis mouse model

May 21, 2007

CF-101 enters clinic for third therapeutic indication

May 18, 2007

QuatRx licenses becocalcidiol to CollaGenex

May 18, 2007

Paramount BioSciences obtains license to SonoLight technology for dermatology indications

May 17, 2007

BF-37 enters phase II study in atopic dermatitis

May 15, 2007

ProCertus BioPharm closes Series A financing

May 14, 2007

P&G terminates Hedgehog agonist hair growth collaboration with Curis

May 11, 2007

CollaGenex discontinues 40 mg cohort in phase II acne study of incyclinide

May 10, 2007

UK-371804: a novel selective urokinase-type plasminogen activator inhibitor from Pfizer

May 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...